Loading...
Ons wil graag hê dat jy deel word van ons gemeenskap. Sluit aan by ons Discord om met ons en ander lede te skakel!
- Ticker
- NMRA
- Price
- 0.79
- Stock movement up
- +0.01 (0.73%)
- Company name
- Neumora Therapeutics, Inc.
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Markkapitalisasie
- 127.24M
- Ondernemingswaarde
- -
- Prys/Verkope
- -
- Prys/Boek
- -
- Dividendopbrengs
- -
- Dividendgroei
- -
- Groei jare
- -
- FCF uitbetaling
- -
- Agterlopende P/E
- -
- Volgende P/E
- -
- PEG
- -
- EPS groei
- -
- 1 jaar opbrengs
- -91.62%
- 3 jaar opbrengs
- -
- 5 jaar opbrengs
- -
- 10 jaar opbrengs
- -
Laaste opgedateer: 2025-08-27
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDE
NMRA betaal nie dividende nie of geen data is ontvang nie
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
WAARDERING
Waarderingsverhoudings
Loading...
Waarderingsverhoudings gegewens
| Agterlopende P/E | - |
| Prys tot OCF | - |
| Prys tot FCF | - |
| Prys tot EBITDA | - |
| EV tot EBITDA | - |
Waardering (Verkope/Boekwaarde)
Loading...
Waardering (Verkope/Boekwaarde) gegewens
| Prys tot verkope | - |
| Prys tot Boekwaarde | - |
| EV tot verkope | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANSIËLE
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
AANDELE INLIGTING
Aandele grafiek
Loading...
Aandele prys data
| Open | 0.77 |
| Daaglikse hoog | 0.81 |
| Daaglikse laag | 0.76 |
| Daaglikse volume | 875K |
| Hoogtepunt van alle tye | 19.76 |
| 1j analiseraaming | 6.05 |
| Beta | - |
| EPS (TTM) | - |
| Dividend per aandeel | - |
| Ex-dividend datum | - |
| Volgende verdienste datum | 29 Oct 2025 |
Afwaartse potensiaal
Loading...
Afwaartse potensiaal gegewens
| NMRA | S&P500 | |
| Huidige prysdaling vanaf die hoogste punt van alle tye | -96.02% | -3.04% |
| Hoogste prysdaling | -96.89% | -56.47% |
| Datum van hoogste daling | 14 May 2025 | 9 Mar 2009 |
| Gemiddelde daling vanaf hoogtepunt | -49.00% | -11.04% |
| Gemiddelde tyd tot nuwe hoogtepunt | 55 days | 12 days |
| Maksimum tyd tot nuwe hoogtepunt | 336 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
MAATSKAPPY BESONDERHEDE
Markkapitalisasie
127.24M
Markkapitalisasie kategorie
Small-cap
Beskrywing
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease. In addition, the company's preclinical phase product includes NMRA-NMDA and NMRA-M4R for the treatment of Schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.
Werknemers
96
Webwerf
Beleggerverhoudings
-
SEC lêers
CEO
Land
USA
Stad
Aandele tipe
-
CCC status
-
Dividendfrekwensie
-
GEBEURE EN AANBIEDINGS
GebeureAanbiedings
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VERSTAAN DIE BESIGHEID
Loading...
MAATSKAPPY NUUS
Seeking AlphaPersvrystellings
iO Charts is a Seeking Alpha partnerVolgende bladsy